China SXT Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
This webpage contains a zero-cost E,S&G analysis covering China SXT Pharmaceuticals Inc. This ESG score covers seventeen UN SDGs including: 'Gender Equality', 'Reduced Inequalities' and 'Life on Land'. This webpage includes a questions and answers section on China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | China SXT Pharmaceuticals Inc | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does China SXT Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Does China SXT Pharmaceuticals Inc disclose current and historical energy intensity?
Does China SXT Pharmaceuticals Inc report the average age of the workforce?
Does China SXT Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Does China SXT Pharmaceuticals Inc disclose its ethnicity pay gap?
Does China SXT Pharmaceuticals Inc disclose cybersecurity risks?
Does China SXT Pharmaceuticals Inc offer flexible work?
Does China SXT Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does China SXT Pharmaceuticals Inc disclose the number of employees in R&D functions?
Does China SXT Pharmaceuticals Inc conduct supply chain audits?
Does China SXT Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does China SXT Pharmaceuticals Inc conduct 360 degree staff reviews?
Does China SXT Pharmaceuticals Inc disclose the individual responsible for D&I?
Does China SXT Pharmaceuticals Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does China SXT Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Does China SXT Pharmaceuticals Inc disclose water use targets?
Does China SXT Pharmaceuticals Inc have careers partnerships with academic institutions?
Did China SXT Pharmaceuticals Inc have a product recall in the last two years?
Does China SXT Pharmaceuticals Inc disclose incidents of discrimination?
Does China SXT Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Has China SXT Pharmaceuticals Inc issued a profit warning in the past 24 months?
Does China SXT Pharmaceuticals Inc disclose parental leave metrics?
Does China SXT Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Does China SXT Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does China SXT Pharmaceuticals Inc disclose the pay ratio of women to men?
Does China SXT Pharmaceuticals Inc support suppliers with sustainability related research and development?
Does China SXT Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does China SXT Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is China SXT Pharmaceuticals Inc involved in embryonic stem cell research?
Does China SXT Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Does China SXT Pharmaceuticals Inc disclose its waste policy?
Does China SXT Pharmaceuticals Inc report according to TCFD requirements?
Does China SXT Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does China SXT Pharmaceuticals Inc disclose energy use targets?
Does China SXT Pharmaceuticals Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does China SXT Pharmaceuticals Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for China SXT Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.